Literature DB >> 26460354

Hypertension: sFlt-1 removal seems to be beneficial in women with pre-eclampsia.

Ellen F Carney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26460354     DOI： 10.1038/nrneph.2015.168

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.

Authors:  Ravi Thadhani; Henning Hagmann; Wiebke Schaarschmidt; Bernhard Roth; Tuelay Cingoez; S Ananth Karumanchi; Julia Wenger; Kathryn J Lucchesi; Hector Tamez; Tom Lindner; Alexander Fridman; Ulrich Thome; Angela Kribs; Marco Danner; Stefanie Hamacher; Peter Mallmann; Holger Stepan; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2015-09-24       Impact factor: 10.121
  1 in total
  3 in total

Review 1.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

2.  Deletion of GIT1 Impacts eNOS Activity To Aggravate sFlt-1-Induced Preeclampsia Phenotype in Mice.

Authors:  Shenghong Zhang; Cuili Zou; Qiaoqin Zhang
Journal:  G3 (Bethesda)       Date:  2018-10-03       Impact factor: 3.154

3.  Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.

Authors:  Xudong Zhao; Xietong Wang
Journal:  Mol Med Rep       Date:  2018-05-23       Impact factor: 2.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.